Pronóstico del mercado de diagnóstico molecular en el punto de atención de América del Sur y Central hasta 2028: impacto de COVID-19 y análisis regional por productos y servicios (ensayos y kits, instrumentos, servicios y software), tecnología (PCR, tecnología de amplificación isotérmica de ácidos nucleicos ( INAAT) y otras tecnologías), aplicación (enfermedades infecciosas, oncología, hematología, pruebas prenatales, endocrinología y otras aplicaciones), usuario final (hospitales y clínicas, laboratorios de diagnóstico, institutos académicos y de investigación, y otros)
Introducción al mercado
Los diagnósticos moleculares en el punto de atención incluyen dispositivos portátiles y ensayos y ; kits utilizados para detectar y diagnosticar enfermedades en muestras humanas, como hisopos de garganta, sangre, suero y heces. El diagnóstico molecular está pasando de laboratorios centralizados a pruebas moleculares descentralizadas en el lugar de atención. Debido a su simplicidad, conveniencia, tiempo de respuesta rápido y potencial para mejorar los resultados de los pacientes, POCT está ganando terreno rápidamente.
Además, la creciente demanda de métodos de detección viral específicos que consumen Se espera que menos tiempo para el control oportuno de infecciones impulse el crecimiento del mercado durante el período de pronóstico.
Brasil ha reportado el mayor número de casos de COVID-19 en América del Sur y Central, seguido por Argentina, Perú, Chile y Ecuador, entre otros. Los gobiernos de los países de esta región han tomado varias medidas para proteger a sus ciudadanos y contener la propagación de la enfermedad. La continua propagación de COVID-19 está impulsando el crecimiento del mercado de diagnóstico en el punto de atención. Además, también se prevé que el aumento en la demanda de soluciones de diagnóstico modernizadas para COVID-19 tenga un impacto positivo en el crecimiento del mercado de diagnóstico molecular en el punto de atención de América del Sur y Central.
< span>
Descripción general y dinámica del mercado
El Sur & Se espera que el mercado Centroamericano de diagnóstico molecular en el punto de atención alcance los 282,2 millones de dólares en 2028 desde los 123,4 millones de dólares en 2021. Se estima que el mercado crecerá a una tasa compuesta anual del 12,5% entre 2021 y 2028. El auge de los dispositivos electrónicos de consumo conectados ha transformado sectores enteros de la economía, incluida la atención sanitaria. Los pacientes y consumidores están adaptando sus interacciones con los productos y productos médicos POC. servicios debido a la penetración de los dispositivos móviles. Además, con el auge de los dispositivos conectados, los consumidores están transformando la forma en que gestionan y toman control de su salud. Por lo tanto, los fabricantes están desarrollando dispositivos de diagnóstico molecular POC fáciles de usar, prácticos y asequibles para entornos fuera del laboratorio para satisfacer la creciente demanda de los consumidores. Se prevé que los dispositivos de monitoreo y diagnóstico molecular POC se conviertan en algo común en el futuro en entornos residenciales de economías de ingresos bajos y medios debido al panorama tecnológico que emerge rápidamente y a la creciente penetración de teléfonos inteligentes y dispositivos conectados.
Segmentos de mercado clave
En términos de producto y calidad. servicios, el segmento de ensayos y kits representó la mayor proporción de los mercados del Sur y del Sur. Mercado de diagnóstico molecular en el punto de atención de Centroamérica en 2020. En términos de tecnología, el segmento de PCR representó la mayor participación del mercado de América Central y del Sur. Mercado de diagnóstico molecular en el punto de atención de Centroamérica en 2020. En términos de aplicación, el segmento de enfermedades infecciosas representó la mayor proporción del mercado de América Central y del Sur. Mercado de diagnóstico molecular en el punto de atención de Centroamérica en 2020. En términos de usuario final, el segmento de laboratorios de diagnóstico representó la mayor participación del mercado de América del Sur y del Sur. Mercado de diagnóstico molecular en el punto de atención de Centroamérica en 2020.
Principales fuentes y empresas enumeradas
Algunas de las principales fuentes primarias y secundarias a las que se hizo referencia para preparar este informe sobre el mercado de diagnóstico molecular en el punto de atención en América del Sur y del Sur. Centroamérica se encuentran sitios web de empresas, informes anuales, informes financieros, documentos del gobierno nacional y bases de datos estadísticos, entre otros. Las principales empresas que figuran en el informe son bioMérieux SA, F. Hoffmann-La Roche Ltd., Danaher Corporation, Enzo Biochem, Inc., Abbott, Meridian BioScience, Inc., Biocartis, Quidel Corporation y Bio-Rad Laboratories, Inc. .
Informe de razones para comprar
- Comprender el Sur y el Sur. Panorama del mercado de Diagnóstico Molecular en el Punto de Atención de Centroamérica e identificar segmentos de mercado que probablemente garanticen un fuerte retorno
- Para comprender el panorama del mercado en constante cambio y mantenerse a la vanguardia de la competencia
- Planificar eficientemente fusiones y adquisiciones, y acuerdos de asociación en el Sur y el Sur. Mercado Centroamericano de diagnóstico molecular en el punto de atención identificando segmentos con las ventas probables más prometedoras
- Para tomar decisiones comerciales informadas a partir de un análisis perspicaz y completo del desempeño del mercado de varios segmentos
- Para obtener una previsión de ingresos de mercado del Sur y del Sur. Mercado de diagnóstico molecular en el punto de atención de Centroamérica basado en varios segmentos para el período 2021-2028
SUR & SEGMENTACIÓN DEL MERCADO DE DIAGNÓSTICO MOLECULAR EN PUNTOS DE ATENCIÓN EN CENTROAMÉRICA
< span>Por Producto & Servicios
- Ensayos y kits
- Instrumentos
- Servicios y software
Por tecnología
- PCR
- Tecnología de amplificación isotérmica de ácidos nucleicos (INAAT)
- Otras tecnologías
Por Aplicación
- Enfermedades infecciosas
- Oncología
- Hematología
- Pruebas prenatales
- Endocrinología
- Otras aplicaciones
Por Usuario final
- Hospitales y clínicas
- Laboratorios de diagnóstico
- Institutos académicos y de investigación
- Otros
Por país
- Sur y Asia Centroamérica
- Brasil
- Argentina
- Resto del Sur y América Centroamérica
Empresas mencionadas
- bioMérieux SA
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Enzo Biochem, Inc.
- Abbott
- Meridian BioScience, Inc.
- Biocartis
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Point-of-Care Molecular Diagnostics Market – By Product & Services
1.3.2 South & Central America Point-of-Care Molecular Diagnostics Market – By Technology
1.3.3 South & Central America Point-of-Care Molecular Diagnostics Market – By Application
1.3.4 South & Central America Point-of-Care Molecular Diagnostics Market – By End User
1.3.5 South & Central America Point-of-Care Molecular Diagnostics Market– By Geography
2. South & Central America Point-of-Care Molecular Diagnostics Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Point-of-Care Molecular Diagnostics Market– Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America – PEST Analysis
4.3 Experts Opinion
5. Point-of-Care Molecular Diagnostics Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Demand for Specific Viral Detection Methods that Consume Less Time for Timely Infection Control
5.1.2 Rising Incidences of Infectious Diseases
5.2 Market Restraints
5.2.1 Pricing Pressures owing to Reimbursement Cuts
5.3 Market Opportunities
5.3.1 Rising R&D and Innovation in Point-of-Care Molecular Diagnostics
5.4 Future Trends
5.4.1 Rising Implementation of Molecular Point-of-Care Diagnostic Devices and Kits across Residential Setting
5.5 Impact Analysis
6. Point-of-Care Molecular Diagnostics Market– South & Central America Analysis
6.1 South & Central America Point-of-Care Molecular Diagnostics Market Revenue Forecast and Analysis
7. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Product & services
7.1 Overview
7.2 Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)
7.3 Assays and Kits
7.3.1 Overview
7.3.2 Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Services and Software
7.5.1 Overview
7.5.2 Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By Technology
8.1 Overview
8.2 Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)
8.3 PCR
8.3.1 Overview
8.3.2 PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Isothermal Nucleic Acid Amplification Technology (INAAT)
8.4.1 Overview
8.4.2 Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Others
8.5.1 Overview
8.5.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9. Point-of-Care Molecular Diagnostics Market Analysis – By Application
9.1 Overview
9.2 Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)
9.3 Infectious Disease
9.3.1 Overview
9.3.2 Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Oncology
9.4.1 Overview
9.4.2 Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Hematology
9.5.1 Overview
9.5.2 Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.6 Prenatal Testing
9.6.1 Overview
9.6.2 Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.7 Endocrinology
9.7.1 Overview
9.7.2 Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
9.8 Others
9.8.1 Overview
9.8.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10. Point-of-Care Molecular Diagnostics Market Analysis and Forecast to 2028 – By End User
10.1 Overview
10.2 Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)
10.3 Hospitals and Clinics
10.3.1 Overview
10.3.2 Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.4 Diagnostic Laboratories
10.4.1 Overview
10.4.2 Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.5 Research and Academic Institutes
10.5.1 Overview
10.5.2 Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
10.6 Others
10.6.1 Overview
10.6.2 Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
11. South & Central America Point-of-Care Molecular Diagnostics Market – Geographic Analysis
11.1 South and Central America: Point-of-Care Molecular Diagnostics Market
11.1.1 Overview
11.1.2 South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.3 South and Central America: Point-of-Care Molecular Diagnostics Market - By Product and Service, 2019-2028 (US$ Million)
11.1.4 South and Central America: Point-of-Care Molecular Diagnostics Market - By Technology, 2019-2028 (US$ Million)
11.1.5 South and Central America: Point-of-Care Molecular Diagnostics Market - By Application, 2019-2028 (US$ Million)
11.1.6 South and Central America: Point-of-Care Molecular Diagnostics Market - By End User, 2019-2028 (US$ Million)
11.1.7 South and Central America: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
11.1.7.1 Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.1 Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.1.2 Brazil: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.1.7.1.3 Brazil: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.1.7.1.4 Brazil: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.1.7.1.5 Brazil: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.1.7.2 Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.1 Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.2.2 Argentina: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.1.7.2.3 Argentina: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.1.7.2.4 Argentina: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.1.7.2.5 Argentina: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
11.1.7.3 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.1 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
11.1.7.3.2 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service, 2019-2028 (US$ Million)
11.1.7.3.3 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology, 2019-2028 (US$ Million)
11.1.7.3.4 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Application, 2019-2028 (US$ Million)
11.1.7.3.5 Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By End User, 2019-2028 (US$ Million)
12. Impact Of COVID-19 Pandemic on Point-of-Care Molecular Diagnostics Market
12.1 South & Central America: Impact Assessment of COVID-19 Pandemic
13. Point-of-Care Molecular Diagnostics Market– Industry Landscape
13.1 Overview
13.2 Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
13.3 Organic Growth Strategies
13.3.1 Overview
13.4 Inorganic Growth Strategies
13.4.1 Overview
14. Company Profiles
14.1 F. Hoffmann-La Roche Ltd.
14.1.1 Key Facts
14.1.2 Business Description
14.1.3 Products and Services
14.1.4 Financial Overview
14.1.5 SWOT Analysis
14.1.6 Key Developments
14.2 bioMérieux SA
14.2.1 Key Facts
14.2.2 Business Description
14.2.3 Products and Services
14.2.4 Financial Overview
14.2.5 SWOT Analysis
14.2.6 Key Developments
14.3 Abbott
14.3.1 Key Facts
14.3.2 Business Description
14.3.3 Products and Services
14.3.4 Financial Overview
14.3.5 SWOT Analysis
14.3.6 Key Developments
14.4 MERIDIAN BIOSCIENCE, INC.
14.4.1 Key Facts
14.4.2 Business Description
14.4.3 Products and Services
14.4.4 Financial Overview
14.4.5 SWOT Analysis
14.4.6 Key Developments
14.5 Enzo Biochem Inc.
14.5.1 Key Facts
14.5.2 Business Description
14.5.3 Products and Services
14.5.4 Financial Overview
14.5.5 SWOT Analysis
14.5.6 Key Developments
14.6 Biocartis
14.6.1 Key Facts
14.6.2 Business Description
14.6.3 Products and Services
14.6.4 Financial Overview
14.6.5 SWOT Analysis
14.6.6 Key Developments
14.7 Quidel Corporation
14.7.1 Key Facts
14.7.2 Business Description
14.7.3 Products and Services
14.7.4 Financial Overview
14.7.5 SWOT Analysis
14.7.6 Key Developments
14.8 Danaher
14.8.1 Key Facts
14.8.2 Business Description
14.8.3 Products and Services
14.8.4 Financial Overview
14.8.5 SWOT Analysis
14.8.6 Key Developments
14.9 BIO-RAD LABORATORIES INC.
14.9.1 Key Facts
14.9.2 Business Description
14.9.3 Products and Services
14.9.4 Financial Overview
14.9.5 SWOT Analysis
14.9.6 Key Developments
15. Appendix
15.1 About The Insight Partners
15.2 Glossary of Terms
LIST OF TABLES
Table 1. South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 2. South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 3. South and Central America: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 4. South and Central America: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 5. Brazil: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 6. Brazil: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 7. Brazil: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 8. Brazil: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 9. Argentina: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 10. Argentina: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 11. Argentina: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 12. Argentina: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 13. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Product and Service - Revenue and Forecast to 2028 (US$ Million)
Table 14. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Technology- Revenue and Forecast to 2028 (US$ Million)
Table 15. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By Application - Revenue and Forecast to 2028 (US$ Million)
Table 16. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market, By End User - Revenue and Forecast to 2028 (US$ Million)
Table 17. Recent Organic Developments the Point-of-Care Molecular Diagnostics Market
Table 18. Recent Inorganic Developments in the Point-of-Care Molecular Diagnostics Market
Table 19. Glossary of Terms, Point-of-Care Molecular Diagnostics Market
LIST OF FIGURES
Figure 1. Point-of-Care Molecular Diagnostics Market Segmentation
Figure 2. South & Central America Point-of-Care Molecular Diagnostics Market Overview
Figure 3. Assays and Kits Segment Held the Largest Share by Product & services in South & Central America Point-of-Care Molecular Diagnostics Market
Figure 4. Brazil to Show Significant Growth During Forecast Period
Figure 5. South & Central America Point-of-Care Molecular Diagnostics Market, Industry Landscape
Figure 6. South & Central America PEST Analysis
Figure 7. South & Central America Point-of-Care Molecular Diagnostics Market– Revenue Forecast and Analysis – 2020- 2028
Figure 8. Point-of-Care Molecular Diagnostics Market, by Product & services 2020 & 2028 (%)
Figure 9. Assays and Kits: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. Instruments: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Services and Software: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Point-of-Care Molecular Diagnostics Market, by Technology 2020 & 2028 (%)
Figure 13. PCR: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Isothermal Nucleic Acid Amplification Technology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Point-of-Care Molecular Diagnostics Market, by Application 2020 & 2028 (%)
Figure 17. Infectious Disease: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Oncology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Hematology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Prenatal Testing: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Endocrinology: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Point-of-Care Molecular Diagnostics Market, by End User 2020 & 2028 (%)
Figure 24. Hospitals and Clinics: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Diagnostic Laboratories: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Research and Academic Institutes: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Others: Point-of-Care Molecular Diagnostics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. South and Central America: Point-of-Care Molecular Diagnostics Market, by Key Country- Revenue (2021) (US$ Million)
Figure 29. South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 30. South and Central America: Point-of-Care Molecular Diagnostics Market, By Country, 2021 & 2028 (%)
Figure 31. Brazil: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 32. Argentina: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 33. Rest of South and Central America: Point-of-Care Molecular Diagnostics Market - Revenue and Forecast to 2028 (US$ Million)
Figure 34. Impact of COVID-19 Pandemic on Point-of-Care Molecular Diagnostic Market in South & Central America
Figure 35. Growth Strategies in the Point-of-Care Molecular Diagnostics Market, 2018-2021
- bioMérieux SA
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation
- Enzo Biochem, Inc.
- Abbott
- Meridian BioScience, Inc.
- Biocartis
- Quidel Corporation
- Bio-Rad Laboratories, Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the South & Central America Point-of-Care molecular diagnostics market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the South & Central America Point-of-Care molecular diagnostics market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.